The promise of human induced pluripotent stem cells for research and therapy - PubMed (original) (raw)
Review
doi: 10.1038/nrm2466.
Affiliations
- PMID: 18698329
- DOI: 10.1038/nrm2466
Review
The promise of human induced pluripotent stem cells for research and therapy
Shin-ichi Nishikawa et al. Nat Rev Mol Cell Biol. 2008 Sep.
Abstract
Induced pluripotent stem (iPS) cells are human somatic cells that have been reprogrammed to a pluripotent state. There are several hurdles to be overcome before iPS cells can be considered as a potential patient-specific cell therapy, and it will be crucial to characterize the developmental potential of human iPS cell lines. As a research tool, iPS-cell technology provides opportunities to study normal development and to understand reprogramming. iPS cells can have an immediate impact as models for human diseases, including cancer
Similar articles
- Generation of human-induced pluripotent stem cells.
Park IH, Lerou PH, Zhao R, Huo H, Daley GQ. Park IH, et al. Nat Protoc. 2008;3(7):1180-6. doi: 10.1038/nprot.2008.92. Nat Protoc. 2008. PMID: 18600223 - Induced human pluripotent stem cells: promises and open questions.
Rolletschek A, Wobus AM. Rolletschek A, et al. Biol Chem. 2009 Sep;390(9):845-9. doi: 10.1515/BC.2009.103. Biol Chem. 2009. PMID: 19558327 Review. - Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states.
Hotta A, Ellis J. Hotta A, et al. J Cell Biochem. 2008 Nov 1;105(4):940-8. doi: 10.1002/jcb.21912. J Cell Biochem. 2008. PMID: 18773452 Review. - Genomic analysis of induced pluripotent stem (iPS) cells: routes to reprogramming.
Kanawaty A, Henderson J. Kanawaty A, et al. Bioessays. 2009 Feb;31(2):134-8. doi: 10.1002/bies.200800204. Bioessays. 2009. PMID: 19204985 - Induced pluripotent stem cells: will they be safe?
Jalving M, Schepers H. Jalving M, et al. Curr Opin Mol Ther. 2009 Aug;11(4):383-93. Curr Opin Mol Ther. 2009. PMID: 19649983 Review.
Cited by
- A Novel Recombinant Vitronectin Variant Supports the Expansion and Differentiation of Pluripotent Stem Cells in Defined Animal-Free Workflows.
Lu X, Perr E, Naqvi T, Galitz D, Andersen M, Grabowski D, Person A, Kalyuzhny A, Flynn KC. Lu X, et al. Cells. 2024 Sep 17;13(18):1566. doi: 10.3390/cells13181566. Cells. 2024. PMID: 39329750 Free PMC article. - A retinoid analogue, TTNPB, promotes clonal expansion of human pluripotent stem cells by upregulating CLDN2 and HoxA1.
Nath SC, Babaei-Abraki S, Meng G, Heale KA, Hsu CYM, Rancourt DE. Nath SC, et al. Commun Biol. 2024 Feb 16;7(1):190. doi: 10.1038/s42003-024-05812-7. Commun Biol. 2024. PMID: 38365890 Free PMC article. - 3D Stem Cell Spheroids with 2D Hetero-Nanostructures for In Vivo Osteogenic and Immunologic Modulated Bone Repair.
Liu X, Astudillo Potes MD, Dashtdar B, Schreiber AC, Tilton M, Li L, Elder BD, Lu L. Liu X, et al. Adv Healthc Mater. 2024 May;13(12):e2303772. doi: 10.1002/adhm.202303772. Epub 2024 Feb 11. Adv Healthc Mater. 2024. PMID: 38271276 - Generation and Characterization of a Human-Derived and Induced Pluripotent Stem Cell (iPSC) Line from an Alzheimer's Disease Patient with Neuropsychiatric Symptoms.
Sagar R, Zivko C, Xydia A, Weisman DC, Lyketsos CG, Mahairaki V. Sagar R, et al. Biomedicines. 2023 Dec 15;11(12):3313. doi: 10.3390/biomedicines11123313. Biomedicines. 2023. PMID: 38137534 Free PMC article. - Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.
Chehelgerdi M, Behdarvand Dehkordi F, Chehelgerdi M, Kabiri H, Salehian-Dehkordi H, Abdolvand M, Salmanizadeh S, Rashidi M, Niazmand A, Ahmadi S, Feizbakhshan S, Kabiri S, Vatandoost N, Ranjbarnejad T. Chehelgerdi M, et al. Mol Cancer. 2023 Nov 28;22(1):189. doi: 10.1186/s12943-023-01873-0. Mol Cancer. 2023. PMID: 38017433 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials